Drug Research
NovelStem Announces Collaborations for Stem-Cell Technology Platform in Cancer Immunotherapy and COVID-19 Resistance
NovelStem International Corp. , a biotechnology company focused on its stem cell-based technology platform, developed by Israel-based affiliate, NewStem Ltd., announced two new collaborations...
Press Releases
INTERPHEX Creates Launch Year-Round Online Resource, RECONNEX 365
International Pharmaceutical Expo (INTERPHEX), the premier event dedicated to pharmaceutical, biotechnology and device innovation, technology and knowledge from development through commercialization, is pleased to...
Drug Research
AdaptVac teams up with AGC Biologics to develop and produce COVID-19 vaccine
AGC Biologics , a leading provider of biopharmaceutical contract development and manufacturing organization (CDMO), announced its partnership with AdaptVac. The partnership was formed to...
Packaging & Labelling
Catalent Biologics Completes $14 Million Commercial Packaging Expansion at its Bloomington, Indiana Facility
Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products,...
Press Releases
Pharnext, UHI to Evaluate Repurposed Drugs Against COVID-19
Pharnext, a clinical-stage biopharma company developing drug combinations based on big genomic data and artificial intelligence (AI), and the University Hospital Institute Méditerranée Infection,...
News
Q BioMed, Mannin Research Accelerate COVID-19 Response Initiatives
Q BioMed Inc., and its technology partner, Mannin Research, are accelerating the rapid development of novel drugs for the treatment of life-threatening complications caused...
News
Cytovance and Akshaya Bio Announce Collaboration Agreement of Therapeutics for Treatment of Coronavirus and Hepatitis B Virus
Cytovance Biologics, a contract development and manufacturing organization (CDMO) and a subsidiary of the Shenzhen Hepalink Pharmaceutical Group Co., Ltd., has entered into a...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read